Befiperide

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBefiperide
Drug Alias NameBefiperidaDU-29325
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 5-HT1 receptors agonists
TargetsSerotonin 5-HT1 receptors
Therapy Area/IndicationsMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbbvie Inc
Active IndicationsN/A
Inactive IndicationsMental Disorders

Other Information

ATC CodeN/A
Related LinksN/A